SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-019864
Filing Date
2024-05-15
Accepted
2024-05-15 16:15:42
Documents
14
Period of Report
2024-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50711
2 ex99-1.htm EX-99.1 108187
  Complete submission text file 0001493152-24-019864.txt   346196

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE xtnt-20240515.xsd EX-101.SCH 3027
4 XBRL LABEL FILE xtnt-20240515_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE xtnt-20240515_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3620
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 24950955
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)